GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
Subscribe To Our Newsletter & Stay Updated
